DK1490103T3 - Fremgangsmåde til fremstilling af en farmaceutisk sammensætning omfattende Mycobacterium w til behandling af astma (obstruktiv lungesygdom) - Google Patents
Fremgangsmåde til fremstilling af en farmaceutisk sammensætning omfattende Mycobacterium w til behandling af astma (obstruktiv lungesygdom)Info
- Publication number
- DK1490103T3 DK1490103T3 DK03706802T DK03706802T DK1490103T3 DK 1490103 T3 DK1490103 T3 DK 1490103T3 DK 03706802 T DK03706802 T DK 03706802T DK 03706802 T DK03706802 T DK 03706802T DK 1490103 T3 DK1490103 T3 DK 1490103T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- mycobacterium
- asthma
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN247MU2002 | 2002-03-13 | ||
| PCT/IB2003/000860 WO2003075826A2 (en) | 2002-03-13 | 2003-03-11 | Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthma(obstructive lung disease) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1490103T3 true DK1490103T3 (da) | 2008-09-29 |
Family
ID=27799871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03706802T DK1490103T3 (da) | 2002-03-13 | 2003-03-11 | Fremgangsmåde til fremstilling af en farmaceutisk sammensætning omfattende Mycobacterium w til behandling af astma (obstruktiv lungesygdom) |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8153102B2 (da) |
| EP (1) | EP1490103B1 (da) |
| JP (1) | JP2005519942A (da) |
| KR (1) | KR20060105058A (da) |
| AT (1) | ATE397940T1 (da) |
| AU (1) | AU2003208510A1 (da) |
| BR (1) | BR0303388A (da) |
| DE (1) | DE60321551D1 (da) |
| DK (1) | DK1490103T3 (da) |
| ES (1) | ES2306857T3 (da) |
| GB (1) | GB2392620B (da) |
| PT (1) | PT1490103E (da) |
| SI (1) | SI1490103T1 (da) |
| WO (1) | WO2003075826A2 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP2752A (en) * | 2006-11-23 | 2013-09-30 | Cadila Pharmaceuticals Ltd | Poly-TLR antagonist |
| WO2008114119A2 (en) * | 2007-03-20 | 2008-09-25 | Cadila Pharmaceuticals Limited | P38 inhibitors |
| CA2691702A1 (en) * | 2007-06-28 | 2008-12-31 | Cadila Pharmaceuticals Ltd. | Mitogen activated protein kinase modulator |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8918206D0 (en) * | 1989-08-09 | 1989-09-20 | Nat Inst Immunology | Tuberculosis vaccine |
-
2003
- 2003-03-11 US US10/565,211 patent/US8153102B2/en not_active Expired - Fee Related
- 2003-03-11 DE DE60321551T patent/DE60321551D1/de not_active Expired - Fee Related
- 2003-03-11 AT AT03706802T patent/ATE397940T1/de not_active IP Right Cessation
- 2003-03-11 AU AU2003208510A patent/AU2003208510A1/en not_active Abandoned
- 2003-03-11 KR KR1020037015466A patent/KR20060105058A/ko not_active Application Discontinuation
- 2003-03-11 PT PT03706802T patent/PT1490103E/pt unknown
- 2003-03-11 BR BR0303388-0A patent/BR0303388A/pt not_active IP Right Cessation
- 2003-03-11 GB GB0400092A patent/GB2392620B/en not_active Expired - Fee Related
- 2003-03-11 WO PCT/IB2003/000860 patent/WO2003075826A2/en active IP Right Grant
- 2003-03-11 SI SI200331280T patent/SI1490103T1/sl unknown
- 2003-03-11 JP JP2003574102A patent/JP2005519942A/ja active Pending
- 2003-03-11 DK DK03706802T patent/DK1490103T3/da active
- 2003-03-11 ES ES03706802T patent/ES2306857T3/es not_active Expired - Lifetime
- 2003-03-11 EP EP03706802A patent/EP1490103B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB2392620B (en) | 2005-02-16 |
| GB2392620A8 (en) | 2004-11-02 |
| US8153102B2 (en) | 2012-04-10 |
| DE60321551D1 (de) | 2008-07-24 |
| AU2003208510A1 (en) | 2003-09-22 |
| AU2003208510A8 (en) | 2003-09-22 |
| EP1490103A2 (en) | 2004-12-29 |
| EP1490103B1 (en) | 2008-06-11 |
| GB0400092D0 (en) | 2004-02-04 |
| US20070059328A1 (en) | 2007-03-15 |
| WO2003075826A3 (en) | 2003-11-13 |
| JP2005519942A (ja) | 2005-07-07 |
| WO2003075826A2 (en) | 2003-09-18 |
| GB2392620A (en) | 2004-03-10 |
| BR0303388A (pt) | 2004-07-20 |
| PT1490103E (pt) | 2008-08-05 |
| ATE397940T1 (de) | 2008-07-15 |
| SI1490103T1 (sl) | 2008-10-31 |
| KR20060105058A (ko) | 2006-10-11 |
| ES2306857T3 (es) | 2008-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1267866T3 (da) | Behandling af respirationssygdomme | |
| SE0301010D0 (sv) | Novel compounds | |
| SE0301009D0 (sv) | Novel compounds | |
| WO2004045618A3 (de) | Neue arzneimittel zur behandlung von chronisch obstruktiver lungenerkrankung | |
| SE0200356D0 (sv) | Novel use | |
| NO20083958L (no) | Prodrugs av GABA-analoger, sammensetninger og anvendelse derav | |
| BRPI0414425A (pt) | composições farmacêuticas | |
| DK1408967T3 (da) | Lægemiddelsammensætninger på basis af tiotropium, ciclesonide og et betamimetikum til behandling af inflammatoriske eller obstruktive luftvejssygdomme | |
| DK1718336T3 (da) | Ny kombination af anticholinergikum og beta-mimetika til behandling af luftvejssygdomme | |
| EA200970487A1 (ru) | Применение пролекарств аналогов гамк для лечения заболеваний | |
| TW200630336A (en) | Novel compounds | |
| BRPI0110947B8 (pt) | processo para a preparação de uma composição farmacêutica e composição farmacêutica assim obtida | |
| TW200716152A (en) | Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture | |
| SG149876A1 (en) | Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same | |
| DK1490103T3 (da) | Fremgangsmåde til fremstilling af en farmaceutisk sammensætning omfattende Mycobacterium w til behandling af astma (obstruktiv lungesygdom) | |
| WO2007036771A3 (en) | Pantoprazole free acid form iii | |
| BR0303387A (pt) | Método para o tratamento de asma, mycobacterium w, e, processo para a fabricação de uma composição farmacêutica utilizável para o tratamento de asma | |
| TW200507851A (en) | A parmaceutical compositions to be absorbed via lung | |
| NO20065635L (no) | 3- eller 4-monosubstituerte fenol og tiofenolderivater nyttige som H3 ligander. | |
| DOP2004000816A (es) | Tratamiento de enfermedades bacterianas de los organos respiratorios | |
| TW200628150A (en) | R-Bambutarol, its preparing method and the application thereof |